NeoPharm CO., LTD. (092730.KQ)

KRW 11960.0

(-0.33%)

Long Term Debt Summary of NeoPharm CO., LTD.

NeoPharm CO., LTD.'s latest annual long term debt in 2023 was 430.04 Million KRW , down 0.0% from previous year.
NeoPharm CO., LTD.'s latest quarterly long term debt in 2024 Q1 was 332.9 Million KRW , up 100.0% from previous quarter.
NeoPharm CO., LTD. reported annual long term debt of - KRW in 2022, down -100.0% from previous year.
NeoPharm CO., LTD. reported annual long term debt of 101.79 Million KRW in 2021, up 425.55% from previous year.
NeoPharm CO., LTD. reported quarterly long term debt of 332.9 Million KRW for 2024 Q1, up 100.0% from previous quarter.
NeoPharm CO., LTD. reported quarterly long term debt of - KRW for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of NeoPharm CO., LTD. (2023 - 2012)

Historical Annual Long Term Debt of NeoPharm CO., LTD. (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	430.04 Million KRW	0.0%
2022	- KRW	-100.0%
2021	101.79 Million KRW	425.55%
2020	19.36 Million KRW	-99.52%
2019	4 Billion KRW	900.0%
2018	400 Million KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%
2012	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	196.01 Million KRW	0.0%
2024 Q1	332.9 Million KRW	100.0%
2023 Q1	- KRW	0.0%
2023 FY	430.04 Million KRW	0.0%
2023 Q4	430.04 Million KRW	154.14%
2023 Q3	169.21 Million KRW	0.0%
2023 Q2	- KRW	0.0%
2022 Q3	- KRW	-100.0%
2022 Q1	56.69 Million KRW	-44.3%
2022 FY	- KRW	-100.0%
2022 Q4	- KRW	0.0%
2022 Q2	14.2 Million KRW	-74.95%
2021 Q4	101.79 Million KRW	-31.26%
2021 Q1	15.25 Million KRW	-21.27%
2021 FY	101.79 Million KRW	425.55%
2021 Q2	11.11 Million KRW	-27.11%
2021 Q3	148.08 Million KRW	1232.29%
2020 FY	19.36 Million KRW	-99.52%
2020 Q4	19.36 Million KRW	-99.52%
2020 Q2	4.02 Billion KRW	-0.1%
2020 Q3	4.02 Billion KRW	-0.1%
2020 Q1	4.03 Billion KRW	0.79%
2019 Q3	- KRW	-100.0%
2019 Q1	400 Million KRW	0.0%
2019 FY	4 Billion KRW	900.0%
2019 Q4	4 Billion KRW	0.0%
2019 Q2	400 Million KRW	0.0%
2018 Q2	- KRW	0.0%
2018 FY	400 Million KRW	0.0%
2018 Q1	- KRW	0.0%
2018 Q4	400 Million KRW	0.0%
2018 Q3	400 Million KRW	0.0%
2017 Q1	- KRW	0.0%
2017 FY	- KRW	0.0%
2017 Q4	- KRW	0.0%
2017 Q3	- KRW	0.0%
2017 Q2	- KRW	0.0%
2016 Q2	- KRW	0.0%
2016 Q4	- KRW	0.0%
2016 Q3	- KRW	0.0%
2016 Q1	- KRW	0.0%
2016 FY	- KRW	0.0%
2015 Q4	- KRW	0.0%
2015 FY	- KRW	0.0%
2013 Q2	900 Million KRW	0.0%
2013 Q3	900 Million KRW	0.0%
2013 Q1	- KRW	0.0%
2012 Q4	- KRW	0.0%
2012 FY	- KRW	0.0%

Peer Long Term Debt Comparison of NeoPharm CO., LTD.

Name	Long Term Debt	Long Term Debt Difference
Kolmar BNH Co., Ltd.	68.42 Billion KRW	99.371%